GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Humana Inc (NYSE:HUM) » Definitions » Debt-to-EBITDA
中文

Humana (Humana) Debt-to-EBITDA

: -14.50 (As of Dec. 2023)
View and export this data going back to 1971. Start your Free Trial

Debt-to-EBITDA measures a company's ability to pay off its debt.

Humana's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1,796 Mil. Humana's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $10,213 Mil. Humana's annualized EBITDA for the quarter that ended in Dec. 2023 was $-828 Mil. Humana's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -14.50.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Humana's Debt-to-EBITDA or its related term are showing as below:

HUM' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.07   Med: 1.72   Max: 2.92
Current: 2.51

During the past 13 years, the highest Debt-to-EBITDA Ratio of Humana was 2.92. The lowest was 1.07. And the median was 1.72.

HUM's Debt-to-EBITDA is ranked worse than
60% of 15 companies
in the Healthcare Plans industry
Industry Median: 2.47 vs HUM: 2.51

Humana Debt-to-EBITDA Historical Data

The historical data trend for Humana's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humana Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 1.27 2.92 2.37 2.51

Humana Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.24 1.54 1.90 2.07 -14.50

Competitive Comparison

For the Healthcare Plans subindustry, Humana's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humana Debt-to-EBITDA Distribution

For the Healthcare Plans industry and Healthcare sector, Humana's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Humana's Debt-to-EBITDA falls into.



Humana Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Humana's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1796 + 10213) / 4793
=2.51

Humana's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1796 + 10213) / -828
=-14.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Humana  (NYSE:HUM) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Humana Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Humana's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Humana (Humana) Business Description

Traded in Other Exchanges
Address
500 West Main Street, Louisville, KY, USA, 40202
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Executives
Susan M Diamond officer: Segment President, Home Bus. 500 W MAIN ST., LOUISVILLE KY 40202
Sanjay K Shetty officer: President, CenterWell 500 W. MAIN STREET, LOUISVILLE KY 40202
George Ii Renaudin officer: President, Medicare & Medicaid 500 W. MAIN SREET, LOUISVILLE KY 40202
Jones David A Jr/ky director C/O HUMANA INC, 500 WEST MAIN STREET, LOUISVILLE KY 40202
Timothy S. Huval officer: Sr. Vice Pres & Chief HR Offic 500 W. MAIN STREET, LOUISVILLE KY 40202
Bruce D Broussard officer: President 500 W. MAIN STREET, C/O HUMANA LAW DEPT., LOUISVILLE KY 40202
Joseph C Ventura officer: Chief Legal Officer & Corp Sec 500 W MAIN STREET, LOUISVILLE KY 40202
William Kevin Fleming officer: President, Hlthcare Svc Sgmt 500 WEST MAIN STREET, LOUISVILLE KY 40202
Timothy Alan Wheatley officer: President, Retail Segment 500 WEST MAIN STREET, LOUISVILLE KY 40202
Samir Deshpande officer: Chief Risk Officer 500 W MAIN STREET, LOUISVILLE KY 40202
Brad D Smith director 1040 13TH AVE, HUNTINGTON WV 25701
John-paul W. Felter officer: SVP, Chief Accting Off & Cont. 500 W MAIN ST, LOUISVILLE KY 40202
Michael A. Koeberlein officer: SVP, Chief Accting Off & Cont. 500 W MAIN ST., LOUISVILLE KY 40202
David T Feinberg director 1299 OCEAN AVENUE, SUITE 1000, SANTA MONICA CA 90401
Agwunobi, M.d. Andrew C. officer: Seg. President, Home Solutions HUMANA INC., 500 W MAIN STREET, LOUISVILLE KY 40202

Humana (Humana) Headlines

From GuruFocus

Q3 2021 Humana Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Humana Inc Investor Update Transcript

By GuruFocus Research 01-23-2024

Q4 2022 Humana Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Humana Inc at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q4 2021 Humana Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Humana Inc at Jefferies Healthcare Conference Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Humana Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024